Chronic administration of dexamethasone results in Fc receptor up-regulation and inhibition of class I antigen expression on macrophages from MRL/lpr autoimmune mice

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 5, 1997, Pages 572-578

  Zuckerman, Steven H ^a   Evans, Glenn F ^a   Bryan, Nancy ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FC RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG THERAPY; ETIOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030806060     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.5.572-578.1997     Document Type: Article

References (51)

1. Adachi, M, R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756-1780.
2. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. H. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndrome: clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198-1215.
3. Apelgren, L. D., D. L Bailey, R. L. Fouts, L. Short, N. Bryan, G. F. Evans, G. E. Sandusky, S. H. Zuckerman, A. Glasebrook, and T. F. Bumol. 1996. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell. Immunol. 173: 55-63.
4. Bartlett, R. R., S. Popovic, and R. X. Raiss. 1988. Development of autoimmunity in MRL/lpr mice and the effects of drugs on this murine disease. Scand. J. Rheumatol. 75:290-299.
5. Beutler, B., and A. Cerami. 1987. Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316:379-385.
6. Boswell, J. M., M. A. Yui, D. W. Burt, and V. E. Kelley. 1988. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 141:3050-3054.
7. Boswell, J. M., M. A. Yui, S. Enders, D. W. Burt, and V. E. Kelley. 1988. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. J. Immunol. 141:118-124.
8. Carlsten, H.,A.Tarkowski, R. Holmdahl, and L. A. Nilsson. 1990. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin. Exp. Immunol. 80:467-473.
9. Cowan, H. B., S. Vick, J. T. Conary, and V. L. Shepherd. 1992. Dexamethasone up-regulates mannose receptor activity by increasing mRNA levels. Arch. Biochem. Biophys. 296:314-320.
10. Dang-Vu, A. P., D. S. Pisetsky, and J. B. Weinberg. 1987. Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice. J. Immunol. 138: 1757-1761.
11. Doeberitz, M. V. K., S. Koch, H. Drzonek, and H. Z. Hausen. 1990. Glucocorticoid hormones reduce the expression of major histocompatibility class I antigens on human epithelial cells. Eur. J. Immunol. 20:35-40.
12. Ettinger, W. H., H. F. Klinefelter, and P. O. Kwiterovitch. 1987. Effect of short-term, low dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis 63:167-172.
13. Evans, G. F., and S. H. Zuckerman. 1989. Pharmacologic modulation of TNF production by endotoxin stimulated macrophages: in vitro and in vivo effects of auranofin and other chrysotherapeutic compounds. Agents Actions 26: 329-334.
14. Fuchs, H. J., C. W. Czarniecki, H. H. Chiu, M. Sniezek, and J. E. Shellito. 1989. Interferon-gamma increases alveolar macrophage Ia antigen expression despite oral administration of dexamethasone to rats. Am. J. Respir. Cell Mol. Biol. 1:525-532.
15. Girard, M. T., S. Hjaltadottir, A. N. Fejes-Toth, and P. M. Guyre. 1987. Glucocorticoids enhance the γ-interferon augmentation of human monocyte immunoglobulin G Fc receptor expression. J. Immunol. 138:3235-3241.
16. Hartwell, D. W., M. J. Fenton, J. S. Levine, and D. Beller. 1995. Aberrant cytokine regulation in macrophages from young autoimmune-prone mice: evidence that the intrinsic defect in MRL macrophage IL-1 expression is transcriptionally controlled. Mol. Immunol. 32:743-751.
17. Hecht, M., M. Muller, M.-L. Lohmann-Matthes, and A. Emmendorffer. 1995. In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL-lpr/lpr mice. J. Leukocyte Biol. 57:242-249.
18. Holmdahl, R. 1989. Estrogen exaggerates lupus but suppresses T-cell dependent autoimmune disease. J. Autoimmun. 2:651-656.
19. Izui, S., R. Merino, M. Ewamoto, and L. Fossati. 1994. Mechanisms of genetic control of murine systemic lupus erythematosus. Springer Semin. Immunopathol. 16:133-152.
20. Kanno, H., O. Tachiwaki, M. Nose, and N. Kyogoku. 1994. Immune complex-degradation ability of macrophages in MRL/Mp-lpr/lpr lupus mice and its regulation by cytokines. Clin. Exp. Immunol. 95:115-121.
21. Keisler, L. W., A. H. Keir, and S. E. Walker. 1991. Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogcsterone and ethinyl estradiol. Autoimmunity 9:21-32.
22. Kelley, V. E., and J. B. Roths. 1982. Increase in macrophage Ia expression in autoimmune mice: role of the lpr gene. J. Immunol. 129:923-925.
23. Kofler, R., R. D. Schreiber, F. J. Dixon, and A. N. Theofilopoulos. 1984. Macrophage I-A/I-E expression and macrophage-stimulating lymphokines in murine lupus. Cell. Immunol. 87:92-100.
24. Lee, S. W., A.-P. Tsou, H. Chan, J. Thomas, K. Petrie, E. M. Eugui, and A. C. Allison. 1988. Glucocorticoids selectively inhibit the transcription of the interleukin 1-β gene and decrease the stability of interleukin 1-β mRNA. Proc. Natl. Acad. Sci. USA 85:1204-1208.
25. Levine, J. S., B. J. Pugh, D. Hartwell, J. M. Fitzpatrick, A. Marshak-Rothstein, and D. Beller. 1993. Interleukin-1 dysregulation is an intrinsic defect in macrophages from MRL autoimmune-prone mice. Eur. J. Immunol. 23: 2951-2958.
26. Linker-Israeli, M., R. J. Deans, D. J. Wallace, J. Prehn, T. Ozeri-Chen, and J. R. Klinenberg. 1991. Elevated levels of endogenous IL-6 in systemic lupus erythematosus: a putative role in pathogenesis. J. Immunol. 147:117-123.
27. Lowrance, J. H., F. X. O'Sullivan, T. E. Caver, W. Waegell, and H. D. Gresham. 1994. Spontaneous elaboration of transforming growth factor β suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J. Exp. Med. 180:1693-1703.
28. Mysler, E., P. Bini, J. Drappa, P. Ramos, S. M. Friedman, P. H. Krammer, and K. B. Elkon. 1994. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93:1029-1034.
29. Nakanishi, A., T. Ashiba, Y. Imai, and T. Osawa. 1987. Functional defects of culture grown bone marrow derived macrophages from autoimmune MRL/ MpJ-lpr/lpr mice. Microbiol. Immunol. 31:155-167.
30. O'Leary, E. C., G. F. Evans, and S. H. Zuckerman. In vivo dexamethasone effects on neutrophil functions in a rat model of acute lung injury. Inflammation, in press.
31. O'Leary, E. C., P. Marder, and S. H. Zuckerman. 1996. Glucocorticoid effects in an endotoxin-induced rat pulmonary inflammation model: differential effects on neutrophil influx, integrin expression, and inflammatory mediators. Am. J. Respir. Cell Mol. Biol. 15:97-106.
32. Pan, L., D. B. Mendel, J. Zurlo, and P. M. Guyre. 1990. Regulation of the steady state level of FcγRI mRNA by IFN-γ and dexamethasone in human monocytes, neutrophils, and U-937 cells. J. Immunol. 145:267-275.
33. Perretti, M., S. K. Wheller, J. G. Harris, and R. J. Flower. 1996. Modulation of ICAM-1 levels on U-937 cells and mouse macrophages by interleukin-1β and dexamethasone. Biochem. Biophys. Res. Commun. 223:112-117.
34. Reeves, W. H., and R. G. Lahita. 1992. Clinical presentation of systemic lupus erythematosus in the adult, p. 369-396. In R. G. Lahita (ed.), Systemic lupus erythematosus. Churchill Livingstone, New York, N.Y.
35. Rinehart, J. J., S. P. Balcerzak, A. L. Sagone, and A. F. LoBuglio. 1975. Effects of corticosteroids on human monocyte function. J. Clin. Invest. 54: 1337-1343.
36. Rothfield, N. 1985. Clinical features of systemic lupus erythematosus, p. 1070-1097. In W. N. Kelley, E. D. Harris, Jr., S. Ruddy, and C. B. Sledge (ed.), Textbook of rheumatology. W. B. Saunders, Philadelphia, Pa.
37. Roubinian, J. R., N. Talal, J. S. Greenspan, J. R. Goodman, and P. K. Siiteri. 1978. Effect of castration and sex hormone treatment on survival, antinucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 147:1568-1583.
38. Ruiz, P., F. Gomez, M. King, R. Lopez, C. Darby, and A. D. Schreiber, 1991. In vivo glucocorticoid modulation of guinea pig splenic macrophage Fey receptors. J. Clin. Invest. 88:149-157.
39. Russell, P. J., and A. D. Steinberg. 1983. Studies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. Clin. Immunol. Immunopathol. 27: 387-402.
40. Sierakowski, S., E. J. Kucharz, R. W. Lightfoot, and J. S. Goodwin. 1989. Impaired T cell activation in patients with systemic lupus erythematosus. J. Clin. Immunol. 9:469-476.
41. Snyder, D. S., and E. R. Unanue. 1982. Corticosteroids inhibit murine macrophage Ia expression and interleukin-1 production. J. Immunol. 129:1803-1805.
42. Steinberg, A. D., K. A. Melez, E. S. Raveche, J. P. Reeves, W. A. Boegel, P. A. Smathers, J. A. Taurog, L. Weinlein, and M. Duvic. 1979. Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum. 22: 1170-1176.
43. Taskinen, M. R., T. Kuusi, H. Yki-Jarvinen, and E. A. Nikkila. 1988. Shortterm effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men. J. Clin. Endocrinol. Metab. 67:291-299.
44. Varma, V. K., T. K. Smith, M. Sorci-Thomas, and W. H. Ettinger. 1992. Dexamethasone increases apolipoprotein A-I concentrations in medium and apolipoprotein A-I mRNA abundance from Hep G2 cells. Metabolism 41: 1075-1080.
45. Via, C. S., G. C. Tsokos, B. Bermas, M. Clerici, and G. M. Shearer. 1993. T cell antigen presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogenous expression of multiple defects. J. Immunol. 151:3914-3922.
46. Warner, L. M., L. M. Adams, and S. N. Sehgal. 1994. Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. Arthritis Rheum. 37:289-297.
47. Warren, M. K., and S. N. Vogel. 1985. Opposing effects of glucocorticoids on interferon-γ-induced murine macrophage Fc receptor and Ia antigen expression. J. Immunol. 134:2462-2469.
48. Zimmerman, J., M. Fainaru, and S. Eisenberg. 1988. The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study. Metabolism 33:521-526.
49. Zuckerman, S. H., and N. Bryan-Poole. 1995. Estrogen-induced alterations in lipoprotein metabolism in autoimmune MRL/lpr mice. Arterioscler. Thromb. Vasc. Biol. 15:1556-1562.
50. Zuckerman, S. H., G. F. Evans, and L. O'Neal. 1993. Exogenous glucocorticoids increase macrophage secretion of apo E by cholesterol-independent pathways. Atherosclerosis 103:43-54.
51. Zuckerman, S. H., and R. Fouts. Unpublished data.